↓ Skip to main content

T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

Overview of attention for article published in Cancer Immunology, Immunotherapy, August 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

patent
2 patents

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
105 Mendeley
Title
T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment
Published in
Cancer Immunology, Immunotherapy, August 2012
DOI 10.1007/s00262-012-1330-5
Pubmed ID
Authors

Saskia J. A. M. Santegoets, Anita G. M. Stam, Sinéad M. Lougheed, Helen Gall, Petra E. T. Scholten, Martine Reijm, Karin Jooss, Natalie Sacks, Kristen Hege, Israel Lowy, Jean-Marie Cuillerot, B. Mary E. von Blomberg, Rik J. Scheper, Alfons J. M. van den Eertwegh, Winald R. Gerritsen, Tanja D. de Gruijl

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 105 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 24 23%
Student > Ph. D. Student 23 22%
Other 8 8%
Student > Master 6 6%
Student > Doctoral Student 5 5%
Other 21 20%
Unknown 18 17%
Readers by discipline Count As %
Medicine and Dentistry 38 36%
Agricultural and Biological Sciences 21 20%
Immunology and Microbiology 7 7%
Biochemistry, Genetics and Molecular Biology 4 4%
Nursing and Health Professions 2 2%
Other 8 8%
Unknown 25 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2022.
All research outputs
#7,459,393
of 22,805,349 outputs
Outputs from Cancer Immunology, Immunotherapy
#1,038
of 2,881 outputs
Outputs of similar age
#55,398
of 167,449 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#12
of 26 outputs
Altmetric has tracked 22,805,349 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,881 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,449 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.